Literature DB >> 22958294

Somatic mutation of a tumor suppressor gene BAP1 is rare in breast, prostate, gastric and colorectal cancers.

Eun Mi Je, Sug Hyung Lee, Nam Jin Yoo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22958294     DOI： 10.1111/j.1600-0463.2012.02909.x

Source DB:  PubMed          Journal:  APMIS        ISSN： 0903-4641            Impact factor:   3.205


× No keyword cloud information.
  8 in total

Review 1.  Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.

Authors:  K Rai; R Pilarski; C M Cebulla; M H Abdel-Rahman
Journal:  Clin Genet       Date:  2015-07-14       Impact factor: 4.438

Review 2.  Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.

Authors:  Louis Masclef; Oumaima Ahmed; Benjamin Estavoyer; Bruno Larrivée; Nathalie Labrecque; Anastasia Nijnik; El Bachir Affar
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 12.067

Review 3.  The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment.

Authors:  Angelo Battaglia
Journal:  Clin Med Insights Oncol       Date:  2014-04-28

4.  BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation.

Authors:  Chan Mi Park; Jae Eun Lee; Jung Hwa Kim
Journal:  Genet Mol Biol       Date:  2020-05-08       Impact factor: 1.771

5.  Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.

Authors:  Matthew Yen; Zongtai Qi; Xuhua Chen; John A Cooper; Robi D Mitra; Michael D Onken
Journal:  BMC Med Genomics       Date:  2018-11-06       Impact factor: 3.063

Review 6.  Targeting the Hippo Pathway in Prostate Cancer: What's New?

Authors:  Kelly Coffey
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.575

7.  Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion.

Authors:  Stefan Steurer; Lara Schwemmer; Claudia Hube-Magg; Franziska Büscheck; Doris Höflmayer; Maria Christina Tsourlakis; Till S Clauditz; Andreas M Luebke; Ronald Simon; Guido Sauter; Jakob Izbicki; Cornelia Schroeder; Thorsten Schlomm; Hartwig Huland; Hans Heinzer; Alexander Haese; Markus Graefen; Cosima Göbel; Sören Weidemann; Patrick Lebok; David Dum; Christoph Fraune; Sarah Minner; Jan Meiners
Journal:  Oncotarget       Date:  2019-12-24

8.  BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.

Authors:  Rong Deng; Yanmin Guo; Lian Li; Jianfeng He; Zhe Qiang; Hailong Zhang; Ran Chen; Yanli Wang; Xian Zhao; Jianxiu Yu
Journal:  Mol Oncol       Date:  2020-11-20       Impact factor: 6.603
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.